← All indications
Giant Cell Tumors
Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.
Subtype terms (2)
More specific conditions that are subtypes of Giant Cell Tumors in the MeSH hierarchy.
- Giant Cell Tumor of Bone
11 drugs (9 approved, 2 experimental)
- Giant Cell Tumor of Tendon Sheath
8 drugs (3 approved, 5 experimental)
Drugs by status
Approved for this indication (1)
Phase 3 trials (1)
Phase 2 trials (4)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (15)
- Bristol-Myers Squibb
- Novartis
- Centre Leon Berard
- Harvard University
- Sarcoma Alliance for Research through Collaboration
- University of Michigan
- Leiden University
- Five Prime Therapeutics
- European Organisation for Research and Treatment of Cancer
- University of Texas at Houston
- University of Nantes
- Government of France
- Iovance
- Shanghai JMT-Bio Inc.
- Instituti Ortopedici Rizzoli
Organization Involved with Phase 1 Indications (2)